196 related articles for article (PubMed ID: 25003232)
1. β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells.
Che MI; Huang J; Hung JS; Lin YC; Huang MJ; Lai HS; Hsu WM; Liang JT; Huang MC
Oncotarget; 2014 Jun; 5(11):3673-84. PubMed ID: 25003232
[TBL] [Abstract][Full Text] [Related]
2. B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via β₁ integrin signaling in neuroblastoma.
Hsu WM; Che MI; Liao YF; Chang HH; Chen CH; Huang YM; Jeng YM; Huang J; Quon MJ; Lee H; Huang HC; Huang MC
Am J Pathol; 2011 Sep; 179(3):1394-404. PubMed ID: 21741930
[TBL] [Abstract][Full Text] [Related]
3. Identification of mammalian glycoproteins with type-I LacdiNAc structures synthesized by the glycosyltransferase B3GALNT2.
Nakane T; Angata K; Sato T; Kaji H; Narimatsu H
J Biol Chem; 2019 May; 294(18):7433-7444. PubMed ID: 30898876
[TBL] [Abstract][Full Text] [Related]
4. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.
Chugh S; Meza J; Sheinin YM; Ponnusamy MP; Batra SK
Br J Cancer; 2016 Jun; 114(12):1376-86. PubMed ID: 27187683
[TBL] [Abstract][Full Text] [Related]
5. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
[TBL] [Abstract][Full Text] [Related]
6. A novel long non-coding RNA from the HOXA6-HOXA5 locus facilitates colon cancer cell growth.
Saijo S; Kuwano Y; Tange S; Rokutan K; Nishida K
BMC Cancer; 2019 Jun; 19(1):532. PubMed ID: 31159758
[TBL] [Abstract][Full Text] [Related]
7. Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation.
Rybak AP; Ingram AJ; Tang D
PLoS One; 2013; 8(4):e61716. PubMed ID: 23620784
[TBL] [Abstract][Full Text] [Related]
8. Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells.
Huang J; Liang JT; Huang HC; Shen TL; Chen HY; Lin NY; Che MI; Lin WC; Huang MC
Mol Cancer Res; 2007 Jun; 5(6):543-52. PubMed ID: 17579116
[TBL] [Abstract][Full Text] [Related]
9. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA 375 regulates proliferation and migration of colon cancer cells by suppressing the CTGF-EGFR signaling pathway.
Alam KJ; Mo JS; Han SH; Park WC; Kim HS; Yun KJ; Chae SC
Int J Cancer; 2017 Oct; 141(8):1614-1629. PubMed ID: 28670764
[TBL] [Abstract][Full Text] [Related]
11. Apical Golgi localization of N,N'-diacetyllactosediamine synthase, beta4GalNAc-T3, is responsible for LacdiNAc expression on gastric mucosa.
Ikehara Y; Sato T; Niwa T; Nakamura S; Gotoh M; Ikehara SK; Kiyohara K; Aoki C; Iwai T; Nakanishi H; Hirabayashi J; Tatematsu M; Narimatsu H
Glycobiology; 2006 Sep; 16(9):777-85. PubMed ID: 16728562
[TBL] [Abstract][Full Text] [Related]
12. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
Kumar Katakam S; Tria V; Sim WC; Yip GW; Molgora S; Karnavas T; Elghonaimy EA; Pelucchi P; Piscitelli E; Ibrahim SA; Zucchi I; Reinbold R; Greve B; Götte M
FEBS J; 2021 Jan; 288(2):486-506. PubMed ID: 32367652
[TBL] [Abstract][Full Text] [Related]
13. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
[TBL] [Abstract][Full Text] [Related]
16. Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.
Müller KM; Tveteraas IH; Aasrum M; Ødegård J; Dawood M; Dajani O; Christoffersen T; Sandnes DL
BMC Cancer; 2011 Oct; 11():421. PubMed ID: 21961726
[TBL] [Abstract][Full Text] [Related]
17. LacdiNAc (GalNAcβ1-4GlcNAc) contributes to self-renewal of mouse embryonic stem cells by regulating leukemia inhibitory factor/STAT3 signaling.
Sasaki N; Shinomi M; Hirano K; Ui-Tei K; Nishihara S
Stem Cells; 2011 Apr; 29(4):641-50. PubMed ID: 21305673
[TBL] [Abstract][Full Text] [Related]
18. The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.
Ullmann P; Rodriguez F; Schmitz M; Meurer SK; Qureshi-Baig K; Felten P; Ginolhac A; Antunes L; Frasquilho S; Zügel N; Weiskirchen R; Haan S; Letellier E
Cancer Res; 2018 Jul; 78(14):3793-3808. PubMed ID: 29748374
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
[TBL] [Abstract][Full Text] [Related]
20. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
